LB
BSX icon

Legacy Bridge’s Boston Scientific BSX Stock Holding History

Legacy Bridge’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
9,696
-4,466
-32% -$243K 0.13% 127
2026
Q1 		$889K Hold
14,162
– – 0.34% 91
2025
Q4 		$1.35M Buy
14,162
+139
+1% +$13.6K 0.55% 65
2025
Q3 		$1.37M Hold
14,023
– – 0.57% 62
2025
Q2 		$1.51M Hold
14,023
– – 0.71% 48
2025
Q1 		$1.41M Hold
14,023
– – 0.79% 47
2024
Q4 		$1.25M Hold
14,023
– – 0.65% 59
2024
Q3 		$1.18M Hold
14,023
– – 0.63% 65
2024
Q2 		$1.08M Hold
14,023
– – 0.64% 65
2024
Q1 		$960K Sell
14,023
-1,400
-9% -$90K 0.56% 71
2023
Q4 		$892K Sell
15,423
-80
-0.5% -$4.27K 0.58% 71
2023
Q3 		$819K Hold
15,503
– – 0.58% 71
2023
Q2 		$839K Buy
15,503
+750
+5% +$39.2K 0.56% 74
2023
Q1 		$738K Buy
14,753
+500
+4% +$23.6K 0.51% 83
2022
Q4 		$659K Buy
14,253
+456
+3% +$19.7K 0.47% 83
2022
Q3 		$534K Hold
13,797
– – 0.43% 90
2022
Q2 		$514K Hold
13,797
– – 0.38% 99
2022
Q1 		$611K Hold
13,797
– – 0.36% 103
2021
Q4 		$586K Buy
13,797
+755
+6% +$31.7K 0.31% 112
2021
Q3 		$566K Sell
13,042
-500
-4% -$22.1K 0.33% 107
2021
Q2 		$579K Hold
13,542
– – 0.33% 108
2021
Q1 		$523K Buy
13,542
+1,425
+12% +$53.9K 0.34% 99
2020
Q4 		$436K Buy
12,117
+1,100
+10% +$39.6K 0.32% 102
2020
Q3 		$421K Sell
11,017
-75
-0.7% -$2.89K 0.38% 92
2020
Q2 		$389K Buy
11,092
+75
+0.7% +$2.7K 0.43% 84
2020
Q1 		$359K Buy
11,017
+375
+4% +$14.6K 0.45% 82
2019
Q4 		$481K Buy
10,642
+1,676
+19% +$70.1K 0.4% 91
2019
Q3 		$365K Sell
8,966
-201
-2% -$8.52K 0.35% 99
2019
Q2 		$394K Buy
9,167
+5,400
+143% +$208K 0.38% 92
2019
Q1 		$145K Buy
3,767
+500
+15% +$19.1K 0.15% 140
2018
Q4 		$115K Buy
+3,267
New +$118K 0.14% 138

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legacy Bridge's BSX Position: Q2 2026 in Review

Legacy Bridge reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $243K and leaving 9,696 shares worth $414K. The position accounts for 0.13% of the portfolio, ranked #127.

Legacy Bridge first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.51M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Legacy Bridge held 9,696 shares of Boston Scientific worth $414K as of Q2 2026.
  • Legacy Bridge sold 4,466 Boston Scientific shares in Q2 2026, an estimated $243K.
  • Boston Scientific made up 0.13% of Legacy Bridge's portfolio in Q2 2026, its #127 holding.
  • Legacy Bridge first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
  • Legacy Bridge's Boston Scientific position peaked at $1.51M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Legacy Bridge's 13F filing for Q2 2026, filed 13 Aug 2026.